quinuclidines has been researched along with oxazoles in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujio, M; Hashimoto, K; Katayama, J; Satoh, H; Takanashi, S; Tanaka, H; Tatsumi, R | 1 |
| Fujio, M; Katayama, J; Magata, Y; Ogawa, M; Tatsumi, R | 1 |
| Fujio, M; Hashimoto, K; Horikawa, T; Katayama, J; Kuriyama, M; Maeda, J; Murozono, T; Numata, A; Satoh, H; Shiigi, Y; Takanashi, S; Tanaka, H; Tatsumi, R | 1 |
| Kohari, Y; Kwon, E; Matsuyama, H; Nakano, H; Osone, K; Seki, C; Takano, N; Takeshita, M | 1 |
4 other study(ies) available for quinuclidines and oxazoles
| Article | Year |
|---|---|
Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3']oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligand.
Topics: Administration, Oral; alpha7 Nicotinic Acetylcholine Receptor; Animals; Antipsychotic Agents; Biological Availability; Blood-Brain Barrier; Brain; Cells, Cultured; Evoked Potentials, Auditory; In Vitro Techniques; Ligands; Neurons; Nicotinic Agonists; Oxazoles; Quinuclidines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Nicotinic; Stereoisomerism; Structure-Activity Relationship | 2005 |
Synthesis and evaluation of [125I]I-TSA as a brain nicotinic acetylcholine receptor alpha7 subtype imaging agent.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Brain; Male; Mice; Oxazoles; Positron-Emission Tomography; Quinuclidines; Radiopharmaceuticals; Receptors, Nicotinic | 2006 |
(R)-3'-(3-methylbenzo[b]thiophen-5-yl)spiro[1-azabicyclo[2,2,2]octane-3,5'-oxazolidin]-2'-one, a novel and potent alpha7 nicotinic acetylcholine receptor partial agonist displays cognitive enhancing properties.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Biological Availability; Cerebral Cortex; Cognition; Cognition Disorders; Dopamine; Evoked Potentials, Auditory; Haplorhini; Hippocampus; In Vitro Techniques; Male; Maze Learning; Membrane Potentials; Neurons; Nicotinic Agonists; Nootropic Agents; Oxazoles; Patch-Clamp Techniques; Quinuclidines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Nicotinic; Stereoisomerism; Structure-Activity Relationship | 2006 |
A novel chiral oxazolidine organocatalyst for the synthesis of an oseltamivir intermediate using a highly enantioselective Diels-Alder reaction of 1,2-dihydropyridine.
Topics: Antiviral Agents; Catalysis; Dihydropyridines; Oseltamivir; Oxazoles; Quinuclidines; Stereoisomerism | 2010 |